These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7290455)
21. [Current developments in prevention of coronary heart disease]. Windler E Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967 [TBL] [Abstract][Full Text] [Related]
22. [HDL subfractions in post-prandial lipidemia]. Richter V; Rassoul F; Purcz T; Kolb HJ; Rotzsch W Z Gesamte Inn Med; 1993 Dec; 48(12):599-604. PubMed ID: 8147032 [TBL] [Abstract][Full Text] [Related]
23. [Lowering of lipids: a true prevention?--a justified therapy?--a true controversy?]. Stähelin HB Schweiz Med Wochenschr; 1980 Mar; 110(13):478-84. PubMed ID: 7375898 [TBL] [Abstract][Full Text] [Related]
24. [Prevention of arteriosclerotic heart and vascular diseases]. Siedek H Wien Med Wochenschr; 1971 Jul; 121(30):575-81. PubMed ID: 5564652 [No Abstract] [Full Text] [Related]
25. [Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies]. Berger M Z Kardiol; 1993 Jul; 82(7):399-405. PubMed ID: 8379238 [TBL] [Abstract][Full Text] [Related]
26. Plasma high density lipoproteins and coronary artery disease. Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063 [TBL] [Abstract][Full Text] [Related]
27. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) study. Kaitosaari T; Rönnemaa T; Raitakari O; Talvia S; Kallio K; Volanen I; Leino A; Jokinen E; Välimäki I; Viikari J; Simell O Circulation; 2003 Aug; 108(6):672-7. PubMed ID: 12885748 [TBL] [Abstract][Full Text] [Related]
28. The epidemiology of plasma high-density lipoprotein cholesterol levels. The Lipid Research Clinics Program Prevalence Study. Summary. Heiss G; Johnson NJ; Reiland S; Davis CE; Tyroler HA Circulation; 1980 Nov; 62(4 Pt 2):IV116-36. PubMed ID: 7418140 [TBL] [Abstract][Full Text] [Related]
29. [Hypercholesterolemia: to treat or not to treat? That is the question]. Ducobu J Rev Med Brux; 1994; 15(3):124-31. PubMed ID: 8066357 [TBL] [Abstract][Full Text] [Related]
30. [The risk factors of atherosclerotic disease. Life style and primary prevention]. Bagnoli L; Bellesi R; Menegazzo G; Meucci I; Ghetti A Recenti Prog Med; 1994 Mar; 85(3):195-203. PubMed ID: 8184204 [TBL] [Abstract][Full Text] [Related]
31. [HDL-cholesterol as an indicator of atherogenic risk in healthy women of advanced age]. Battista P; Di Luzio A; Nubile G; Malandra R; Di Primio R Boll Soc Ital Biol Sper; 1981 Jul; 57(14):1551-4. PubMed ID: 7295416 [TBL] [Abstract][Full Text] [Related]
33. Canadian Consensus Conference on Cholesterol: final report. The Canadian Consensus Conference on the Prevention of Heart and Vascular Disease by Altering Serum Cholesterol and Lipoprotein Risk Factors. CMAJ; 1988; 139(11 Suppl):1-8. PubMed ID: 3069192 [No Abstract] [Full Text] [Related]
34. [Atherosclerosis and possibilities of dietary prevention or therapy]. Spengel FA Wien Med Wochenschr Suppl; 1990; 106():suppl 13-4. PubMed ID: 2219948 [TBL] [Abstract][Full Text] [Related]
35. HDL-cholesterol: the negative risk factor for coronary heart disease. Tan MH Ann Acad Med Singap; 1980 Oct; 9(4):491-5. PubMed ID: 7018364 [TBL] [Abstract][Full Text] [Related]
36. [High-density lipoproteins: the "new" target of cardiovascular medicine]. Sampietro T; Bigazzi F; Dal Pino B; Puntoni M; Bionda A Ital Heart J Suppl; 2005 Jun; 6(6):341-53. PubMed ID: 16013425 [TBL] [Abstract][Full Text] [Related]
37. [Prevention of arteriosclerosis. Current basis]. Gutzwiller F; Junod B Schweiz Med Wochenschr; 1979 Aug; 109(32):1169-70. PubMed ID: 493906 [No Abstract] [Full Text] [Related]
38. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012 [TBL] [Abstract][Full Text] [Related]
39. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Marchioli R; Marfisi RM; Carinci F; Tognoni G Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010 [TBL] [Abstract][Full Text] [Related]
40. [Effectiveness of different intervention measures in children and adolescents with hypertension and lipid metabolism disorders]. Holtz H; Heinrich J; Dück KD; Rühling K; Heller R; Schauer I Z Gesamte Inn Med; 1983 Dec; 38(23):644-9. PubMed ID: 6670341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]